- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Platinum Refractory Epithelial Ovarian Cancer in Australia
Total 417 results
-
Xennials Therapeutics Australia Pty LtdPinotbio, Inc.TerminatedAdvanced Solid Tumor | High-grade Glioma | Platinum-Resistant Ovarian Cancer | Platinum-Resistant Urothelial CarcinomaAustralia
-
AccentureCompletedRecurrent Platinum-resistant Ovarian CancerAustralia, Russian Federation, United Kingdom
-
Sonnet BioTherapeuticsHoffmann-La RocheRecruitingAdvanced Solid Tumor | Platinum-resistant Ovarian CancerUnited States, Australia
-
AstraZenecaMerck Sharp & Dohme LLC; European Network of Gynaecological Oncological Trial... and other collaboratorsActive, not recruitingRelapsed Ovarian Cancer | Following Complete or Partial Response to Platinum Based Chemotherapy | Platinum Sensitive | BRCA MutatedKorea, Republic of, France, China, Italy, United States, Israel, United Kingdom, Canada, Japan, Germany, Brazil, Netherlands, Belgium, Poland, Australia, Russian Federation, Spain
-
Life Research Technologies GmbHUnknownOvarian Epithelial CancerAustria, Hungary
-
Sutro Biopharma, Inc.GOG Foundation; European Network of Gynaecological Oncological Trial Groups... and other collaboratorsRecruitingOvarian Cancer | Fallopian Tube Cancer | Epithelial Ovarian Cancer | Platinum-resistant Ovarian Cancer | Primary Peritoneal CancerUnited States, Australia, Korea, Republic of, Israel, Singapore, Canada
-
Queensland Centre for Gynaecological CancerRoyal Brisbane and Women's Hospital; The University of QueenslandCompletedOvarian Cancer Stage IV | Ovarian Cancer Stage IIIAustralia
-
AGO Research GmbHARCAGY/ GINECO GROUP; Australia New Zealand Gynaecological Oncology Group; Arbeitsgemeinschaft... and other collaboratorsCompletedRecurrent Platinum-sensitive Ovarian CancerFrance, Belgium, Germany, Australia, United Kingdom, Austria
-
Queensland Centre for Gynaecological CancerThe University of Queensland; Cancer Australia Priority-driven Collaborative...CompletedFallopian Tube Cancer | Epithelial Ovarian Cancer | Peritoneal CancerAustralia
-
Mural Oncology, IncMerck Sharp & Dohme LLCRecruitingFallopian Tube Cancer | Platinum-resistant Ovarian Cancer | Primary Peritoneal CancerUnited States, Spain, Korea, Republic of, Taiwan, Canada, Israel, France, United Kingdom, Germany, Belgium, Czechia, Singapore, Australia, Austria, Italy
-
Mersana TherapeuticsIQVIA Biotech; PSI CRORecruitingPlatinum Resistant Ovarian Cancer | Non Small Cell Lung Cancer MetastaticUnited States, Spain, United Kingdom, Australia, France, Austria, Belgium, Bulgaria, Canada, Czechia, Denmark, Finland, Hungary, Italy, Lithuania, New Zealand, Norway, Poland, Sweden
-
AstraZenecaRTI Health Solutions; A+A Healthcare Marketing Research; Freelance CRA (FCRA)CompletedPlatinum-sensitive Recurrent Serous Ovarian CancerFrance, Italy, Korea, Republic of, Spain, United Kingdom, Germany, Belgium, Israel, Portugal, Netherlands, Switzerland, Canada, Australia
-
National University Hospital, SingaporeKK Women's and Children's Hospital; National Cancer Centre, Singapore; Australia...UnknownOvarian Cancer | Fallopian Tube CancerSingapore, Australia
-
Neovii BiotechCompletedOvarian Cancer | Epithelial Ovarian CancerAustria, Germany
-
Paul Speiser, Prof.MD,CompletedCarcinoma in Situ | Ovarian Cancer | Ovarian Epithelial CancerAustria, Czechia, Germany, Ireland
-
Prima BioMed LtdCompletedEpithelial Ovarian CancerUnited States, Australia
-
Medical University of ViennaCompletedOvarian Epithelial CancerAustria, Belgium, Czechia, Germany
-
Krankenhaus Barmherzige Schwestern LinzWithdrawnFallopian Tube Cancer | Epithelial Ovarian Cancer | Peritoneal CancerAustria
-
Prima BioMed LtdCompleted
-
Tesaro, Inc.European Network of Gynaecological Oncological Trial Groups (ENGOT); US Oncology... and other collaboratorsCompletedA Maintenance Study With Niraparib Versus Placebo in Patients With Platinum Sensitive Ovarian CancerOvarian Neoplasms | Platinum Sensitive Ovarian CancerUnited States, Belgium, Sweden, Germany, Israel, Austria, Canada, Denmark, Spain, Italy, United Kingdom, Poland, France, Hungary, Norway
-
Prima BioMed LtdTerminatedEpithelial Ovarian CancerUnited States, Australia
-
Medical University of ViennaCompletedOvarian Epithelial CancerAustria, Germany, Belgium, Czechia
-
Vejle HospitalCompletedEpithelial Ovarian CancerDenmark, Belgium, Sweden, Austria
-
Anthony Joshua, FRACPSt Vincent's Hospital, Sydney; Royal Prince Alfred Hospital, Sydney, Australia and other collaboratorsRecruitingOvarian CancerAustralia
-
MEI Pharma, Inc.CompletedOvarian Cancer | Fallopian Tube Cancer | Primary Peritoneal Cavity CancerUnited States, Australia
-
Walter and Eliza Hall Institute of Medical ResearchJohns Hopkins UniversityActive, not recruitingOvarian CancerAustralia, United States
-
Exscientia GmbHAGO Research GmbHRecruitingEpithelial Ovarian CancerAustria, Germany
-
Medical University of ViennaCompletedCarcinoma in Situ | Ovarian Cancer | Ovarian Epithelial CancerAustria, Belgium, Czechia, Denmark, Germany, Ireland, Netherlands, United Kingdom
-
Medical University InnsbruckRecruitingRecurrent Ovarian CarcinomaAustria
-
Medical University InnsbruckEuropean CommissionTerminatedFallopian Tube Cancer | Epithelial Ovarian Cancer | Primary Peritoneal CancerFrance, Austria, Belgium, Germany
-
Multitude Therapeutics Inc.Tigermed Consulting Co., LtdRecruitingOvarian Cancer | Ovarian Epithelial Cancer | Lung Adenocarcinoma | Ovarian Endometrioid Adenocarcinoma | Triple Negative Breast Cancer | Advanced Solid Tumor | Endometrial Cancer | Advanced Cancer | Ovarian Clear Cell Carcinoma | Pancreatic Ductal Adenocarcinoma | Endometrial Clear Cell Adenocarcinoma | Endometrial... and other conditionsChina, Australia
-
Hoffmann-La RocheCompletedOvarian Cancer, Peritoneal NeoplasmsAustria
-
Novartis PharmaceuticalsTerminatedRenal Cell Carcinoma | Epithelial Ovarian CancerJapan, Australia, Belgium, Spain, United States, Switzerland
-
AmgenCompletedCarcinoma | Ovarian Cancer | Fallopian Tube Cancer | Primary Peritoneal CancerBelgium, Spain, Australia
-
GlaxoSmithKlineCompletedOvarian Cancer | Fallopian Tube Cancer | Peritoneal Cancer | Neoplasms, OvarianUnited States, Australia, Singapore
-
University Health Network, TorontoCompletedFallopian Tube Cancer | Epithelial Ovarian Cancer | Peritoneal CancerCanada, Spain, Australia, Italy, United Kingdom
-
Peter MacCallum Cancer Centre, AustraliaActive, not recruitingOvarian Cancer | Fallopian Tube Cancer | Primary Peritoneal CarcinomaAustralia
-
AmgenActive, not recruitingNon-squamous Non-small Cell Lung Cancer | Epithelial Ovarian Cancer | Claudin 6-positive Advanced/Metastatic Malignant Solid TumorsUnited States, Australia, Switzerland
-
AstraZenecaMerck Sharp & Dohme LLC; GOG Foundation; Myriad Genetic Laboratories, Inc.Active, not recruitingAdvanced Ovarian Cancer | Newly Diagnosed | FIGO Stage III-IV | Partial Response | Complete Response | BRCA Mutation | First Line Platinum ChemotherapyKorea, Republic of, France, Italy, United States, Israel, Canada, China, Brazil, United Kingdom, Poland, Australia, Japan, Netherlands, Russian Federation, Spain
-
K-Group, Beta, Inc., a wholly owned subsidiary...RecruitingFallopian Tube Cancer | Solid Tumor | Epithelial Ovarian Cancer | Peritoneal CancerUnited States, Australia, Bosnia and Herzegovina, Bulgaria, Georgia, Korea, Republic of, Serbia
-
Angle plcMedical University of Vienna; Charite University, Berlin, Germany; Vivantes Netzwerk...CompletedEvaluation of Multiple Biomarkers to Estimate Risk of Ovarian Cancer in Patients With a Pelvic Mass.Ovarian NeoplasmsGermany, Austria
-
EBMT Solid Tumors Working PartyCompletedOvarian CancerSwitzerland, Spain, United Kingdom, Italy, Slovakia, Germany, Belgium, Austria, Czech Republic
-
AmgenCompletedCarcinoma | Cancer | Ovarian Cancer | Fallopian Tube Cancer | Solid Tumors | Oncology | Tumors | Metastases | Gynecological MalignanciesBelgium, United States, Australia
-
Canadian Cancer Trials GroupApotex Inc.Active, not recruiting
-
Eli Lilly and CompanyCompletedFallopian Tube Cancer | Epithelial Ovarian Cancer | Primary Peritoneal CancerUnited States, Australia, Germany, Belgium
-
SanofiRegeneron PharmaceuticalsCompletedNeoplasms | Cancer of the OvaryUnited States, France, Canada, Australia, Germany, Italy, Netherlands, Portugal, Spain, Sweden, Switzerland
-
AstraZenecaKuDOS Pharmaceuticals LimitedCompletedOvarian NeoplasmUnited States, Spain, Australia, Germany, Sweden
-
Hoffmann-La RocheTerminatedTriple Negative Breast Cancer | Advanced Ovarian CancerUnited Kingdom, United States, Australia, Denmark, Canada
-
AbbVie (prior sponsor, Abbott)BiogenCompletedOvarian Cancer, Primary Peritoneal CancerUnited States, Australia, Belgium, Italy, Poland, Russian Federation, Spain, Sweden, Switzerland
-
Hoosier Cancer Research NetworkUniversity of Sydney; Bionomics Limited; Australia New Zealand Gynaecological...WithdrawnOvarian CancerUnited States, Australia, New Zealand